Tanner Health and Healthliant Ventures partner with Optellum to launch an artificial intelligence (AI) platform designed to detect lung cancer.
Researchers identified a 14-protein blood signature that may predict lung cancer years early, potentially enabling earlier ...
As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...
Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before ...
Researchers have identified a 14-protein blood signature that may predict lung cancer risk up to five years before diagnosis, ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to ...
Survival outcomes in non-small cell lung cancer: Real-world analysis of immunotherapy era vs pre-immunotherapy era, with insights into treatment settings, racial disparities, and socioeconomic impacts ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results